MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Regeneron Pharmaceuticals Company Profile (NASDAQ:REGN)

Consensus Ratings for Regeneron Pharmaceuticals (NASDAQ:REGN) (?)
Ratings Breakdown: 1 Sell Rating(s), 13 Hold Rating(s), 13 Buy Rating(s)
Consensus Rating:Hold (Score: 2.44)
Consensus Price Target: $512.13 (29.25% upside)

Analysts' Ratings History for Regeneron Pharmaceuticals (NASDAQ:REGN)
Show:
DateFirmActionRatingPrice TargetActions
5/23/2016Wells FargoReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Robert W. BairdReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2016Leerink SwannReiterated RatingBuy$523.00 -> $530.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2016Piper JaffrayReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016Canaccord GenuityReiterated RatingHold$450.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/19/2016Jefferies GroupReiterated RatingHold$444.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2016Morgan StanleyLower Price Target$436.00 -> $415.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2016Roth CapitalReiterated RatingBuy$555.00 -> $520.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016Credit SuisseReiterated RatingHold$481.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2016Chardan CapitalReiterated RatingSell$325.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2016Goldman SachsReiterated RatingBuy$506.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016SunTrustLower Price TargetNeutral$450.00 -> $410.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016GabelliInitiated CoverageBuy$574.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/13/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2016Citigroup Inc.Initiated CoverageBuy$480.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Bank of AmericaReiterated RatingBuy$649.00 -> $525.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016RBC CapitalReiterated RatingOutperform$676.00 -> $668.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016BarclaysLower Price TargetEqual Weight$610.00 -> $425.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016BTIG ResearchInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/31/2015Raymond JamesInitiated CoverageOutperform$615.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2015ArgusBoost Price TargetBuy$560.00 -> $660.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015Sanford C. BernsteinReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015Deutsche BankReiterated RatingBuy$650.00 -> $720.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2015BMO Capital MarketsReiterated RatingMarket Perform$381.00 -> $494.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2015Northland SecuritiesInitiated CoverageMarket Perform$560.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014GuggenheimInitiated CoverageBuy$432.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha